Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a small backend or metadata update. No study details or user-facing content were altered.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- The page revision label was updated from v3.5.2 to v3.5.3, indicating a maintenance or template update. The change does not modify the displayed study details or user-facing content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to the study details on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded the NEJM 2015 paper by Larkin et al. on Combined Nivolumab and Ipilimumab for untreated melanoma; removed the Erratum entry for that publication.SummaryDifference0.0%

- Check59 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.